Periphas Capital Partnering priced its IPO of 14.4 million CAPs (Capital which Aligns and Partners with a Sponsor) at $25 each. The $360 million raise is $60 million more than the SPAC initially planned, as noted in its October S-1 filing, following the registration of an additional 2.76 million units. The offering is epected to close Dec. 14.
The CAPS™ begin trading today on the NYSE under “PCPC.U”. Once the securities comprising the CAPS™ begin separate trading, shares and warrants are expected to list listed under “PCPC” and “PCPC WS,” respectively.
Periphas will focus on tech-enabled companies, consumer businesses, industrials and business services. Read more.
Related Posts
Achari Ventures Holdings I Files for $100M IPO
Achari is led by CEO and Chairman Vikas Desai, who in 2018 founded Welcan Capital, a predecessor of Achari Ventures, a venture capital firm focused on the cannabis industry.
Newcourt Acquisition Shareholders to Vote Next Week on Psyence Biomedical Deal
At deal announcement a year ago, terms called for Psyence to receive a minimum of $20 million cash held in trust. Newcourt raised $220 million in an October 2021 IPO, although the account is now down to approximately $12.8 million as of Jan. 9, according to the proxy.
Aimfinity Investment I Deploys 6th Extension in Pursuit of Docter Inc. Acquisition
Aimfinity in October signed a $60 million merger agreement with Docter Inc., a Taiwanese non-invasive blood glucose watch developer.
Silver Crest Shares & Warrants Begin Separate Trading Today
The SPAC plans to target global or regional businesses with differentiated products and services in one or more high growth consumer and consumer technology sectors.